212 related articles for article (PubMed ID: 15046605)
1. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T; Okahara F; Kanaho Y
Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
[TBL] [Abstract][Full Text] [Related]
2. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
3. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
[TBL] [Abstract][Full Text] [Related]
5. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
[TBL] [Abstract][Full Text] [Related]
6. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
7. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
8. PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
Maehama T; Dixon JE
Trends Cell Biol; 1999 Apr; 9(4):125-8. PubMed ID: 10203785
[TBL] [Abstract][Full Text] [Related]
9. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
Besson A; Robbins SM; Yong VW
Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
[TBL] [Abstract][Full Text] [Related]
10. PTEN function: how normal cells control it and tumour cells lose it.
Leslie NR; Downes CP
Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
[TBL] [Abstract][Full Text] [Related]
11. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
Lin HK; Hu YC; Lee DK; Chang C
Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel effectors of invasive cell growth downstream of phosphoinositide 3-kinase.
Kaufmann J; Pronk G; Giese K; Klippel A
Biochem Soc Trans; 2004 Apr; 32(Pt 2):355-9. PubMed ID: 15046608
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
[TBL] [Abstract][Full Text] [Related]
14. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
Okahara F; Ikawa H; Kanaho Y; Maehama T
J Biol Chem; 2004 Oct; 279(44):45300-3. PubMed ID: 15355975
[TBL] [Abstract][Full Text] [Related]
15. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
16. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
17. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
18. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
Qiao J; Kang J; Cree J; Evers BM; Chung DH
Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504
[TBL] [Abstract][Full Text] [Related]
20. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
Soussi T
Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
[No Abstract] [Full Text] [Related]
[Next] [New Search]